Chemotherapy and Radiation
721 articles
Mary Fisher
The world “discovered” Mary Fisher on the evening of August 19, 1992, when she delivered a speech at the 1992 Republican Convention. It is ranked as one of the 100 greatest American speeches in the 20th Century. Since the steaming night in Houston, the world has come to know Mary as a gifted artist, a […]
An Exemplary Life: The PR Lessons Anne Glauber Left Us
A tribute to the life, works, and pancreatic cancer treatment education mission of Anne Glauber, founder of Let’s Win, by Seth Arenstein.
Let’s Win Inducted into the PR News Platinum Hall of Fame
Let’s Win has been inducted into the PR News Platinum Hall of Fame. Other inductees include the ALS Association’s ice bucket challenge.
In Safe Hands: Selecting the Right Whipple Surgeon
The Whipple procedure is a complex surgery–how do you find an expert with the vast experience needed for your surgery?
Exploring Alternatives to Creon for Pancreatic Enzyme Replacement Therapy
Oncology dietitian Meghan Laszlo explains how pancreatic enzyme replacement drug Creon works and available alternatives.
No Symptoms Whatsoever
Judd Levy had no symptoms when diagnosed with stage IV pancreatic cancer. He responded so well to treatment he was able to have a Whipple.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
What You Should Know About Tumor Boards
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment.
Solving My Problem Saved My Life
Bruce Seibert knew something wasn’t right when he felt nauseous, but was surprised when he was diagnosed with pancreatic cancer, which was followed by a Whipple procedure.
Millicent Fortunoff
Millicent Fortunoff is President of M. Fortunoff Communications. She has extensive experience managing global and national media relations campaigns that build one reputation across regions, yet tailored to local issues and audiences. Prior to opening her own consultancy Ms. Fortunoff was a Senior Vice President in the Global Issues Communications Group at Ruder Finn (Finn […]
Understanding a Family’s Risk for Pancreatic Cancer
A tumor registry studies the genetics of pancreatic cancer to determine risk factors for families.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Finding More Clues about Circulating Tumor DNA
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
Triple Immunotherapy Shows Dramatic Results
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.